Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Surg Obes Relat Dis. 2020 Sep 3;17(1):72–80. doi: 10.1016/j.soard.2020.08.035

Table 1.

Baseline characteristics of SG patients with and without hiatal hernia repair

Variables Unmatched cohorts* Matched cohorts*

SG + hiatal hernia repair (n = 1765) SGonly (n = 5352) Standardized difference SG + hiatal hernia repair (n = 1546) SGonly (n = 3170) Standardized differenc

Age group, n (%) .16 .00
 18–29 yr 570 (32.3) 2077 (38.8) 518 (33.5) 1062 (33.5)
 30–39 yr 602 (34.1) 1764 (33.0) 550 (35.6) 1128 (35.6)
 40–49 yr 466 (26.4) 1191 (22.3) 403 (26.1) 826 (26.1)
 50–64 yr 127 (7.2) 320 (6.0) 75 (4.9) 154 (4.9)
Female sex, n (%) 1415 (80.2) 3949 (73.8) .15 1288 (83.3) 2641 (83.3) .00
Predominantly white neighborhood (≥75%), n (%) 815 (46.2) 2622 (49.0) .07 707 (45.7) 1532 (48.3) .08
Neighborhood below poverty line, n(%), .04 .04
 Less poor (<10%) 798 (45.2) 2321 (43.4) 685 (44.3) 1394 (44.0)
 More poor (≥10%) 816 (46.2) 2557 (47.8) 728 (47.1) 1473 (46.5)
 Missing 151 (8.6) 474 (8.9) 133 (8.6) 303 (9.6)
Region of United States, n (%) .29 .00
 West 290 (16.4) 1053 (19.7) 231 (14.9) 474 (14.9)
 South 1037 (58.8) 2555 (47.7) 959 (62.0) 1966 (62.0)
 Midwest 217 (12.3) 1138 (21.3) 199 (12.9) 408 (12.9)
 Northeast 221 (12.5) 595 (11.1) 157 (10.2) 322 (10.2)
Year of surgery, n (%) .24 .00
 2010–2011 156 (8.8) 611 (11.4) 113 (7.3) 232 (7.3)
 2012–2013 504 (28.6) 1240 (23.2) 442 (28.6) 906 (28.6)
 2014–2015 701 (39.7) 1881 (35.1) 628 (40.6) 1288 (40.6)
 2016–2017 404 (22.9) 1620 (30.3) 363 (23.5) 744 (23.5)
BMI category, n (%), kg/m2 .30 .00
 30–39.9 371 (21.0) 855 (16.0) 304 (19.7) 623 (19.7)
 40–49.9 980 (55.5) 2830 (52.9) 924 (59.8) 1895 (59.8)
 50–59.9 251 (14.2) 912 (17.0) 217 (14.0) 445 (14.0)
 ≥60 44 (2.5) 297 (5.5) 31 (2.0) 64 (2.0)
 Nonspecific obesity 111 (6.3) 431 (8.1) 67 (4.3) 137 (4.3)
 Missing 8 (.5) 27 (.5) 3 (.2) 6 (.2)
GERD, n (%) .61 .00
 No diagnosis 392 (22.2) 2532 (47.3) 350 (22.6) 718 (22.6)
 1 inpatient diagnosis 214 (12.1) 817 (15.3) 154 (10.0) 316 (10.0)
 2+ outpatient diagnoses 1159 (65.7) 2003 (37.4) 1042 (67.4) 2137 (67.4)
Filled prescription for GERD medication, n (%) 686 (38.9) 1652 (30.9) .17 566 (36.6) 1161 (36.6) .00
ACG score ≥3, n (%),|| 344 (19.5) 783 (14.6) .13 287 (18.6) 521 (16.5) .06
Hypertension, n (%) 778 (44.1) 2309 (43.1) .02 646 (41.8) 1351 (42.6) − .02
T2D, n (%) 535 (30.3) 1680 (31.4) −.02 445 (28.8) 968 (30.5) −.04
Cardiovascular disease, n (%) 141 (8.0) 335 (6.3) .07 123 (8.0) 187 (5.9) .08
Psychiatric illness, n (%) 708 (40.1) 2231 (41.7) − .03 635 (41.1) 1348 (42.5) − .03
Tobacco/smoking history, n (%) 310 (17.6) 932 (17.4) .00 267 (17.3) 588 (18.6) − .03
Surgery in inpatient setting, n (%) 1397 (79.2) 3739 (69.9) .21 1225 (79.2) 2335 (73.7) .13

BMI = body mass index; GERD = gastroesophageal reflux disease; ACG = Adjusted Clinical Groups; T2D = type 2 diabetes.

*

We conducted coarsened exact matching on preoperative GERD diagnosis, GERD medication use, age group, sex, baseline BMI category, ACG score, calendar year group of surgery, and United States region. Matched cohorts reflect weighted samples post matching.

Standardized differences are the difference in means between the intervention and control groups divided by the SD of the difference in means. Lower absolute values indicate greater similarity between groups, and values <.2 indicate minimal differences between groups.

For complete descriptions of how we constructed baseline variables, please refer to the Methods section.

Neighborhoods with less poverty were those where <10% of households were below the poverty line; more poverty were those where ≥ 10% of households were below the poverty line.

||

Johns Hopkins Adjusted Clinical Groups System.